However, immunohistochemical evaluation of MPG in the treatment naïve GBM also identified tumors with both nuclear and cytoplasmic MPG expression patterns that displayed a wide range of HTATIP2 expression reflecting tumor heterogeneity (Fig. S1). This evidence concerns the gene HTATIP2 and glioblastoma.